Trials / Unknown
UnknownNCT01399203
Contrast Medium Volume and Contrast-induced Nephropathy After Percutaneous Coronary Intervention
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- Guangdong Provincial People's Hospital · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the predictive value of the contrast media volume to creatinine clearance (V/CrCl) ratio for the risk of contrast-induced nephropathy (CIN) (i.e., within 48-72 h) and to determine a relatively safe V/CrCl cut-off value to avoid CIN in patients following PCI
Detailed description
contrast media volume to creatinine clearance (V/CrCl) ratios were obtained from consecutive consenting patients after unselective PCI. Receiver-operator characteristic (ROC) curves were used to identify the optimal sensitivity for the observed range of V/CrCl. The predictive value of V/CrCl for the risk of CIN was assessed using multivariate logistic regression.
Conditions
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2011-10-01
- Completion
- 2012-01-01
- First posted
- 2011-07-21
- Last updated
- 2011-08-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01399203. Inclusion in this directory is not an endorsement.